Skip to main content
Fig. 3 | BMC Bioinformatics

Fig. 3

From: Risk prediction for dermatomyositis-associated hepatocellular carcinoma

Fig. 3

Expression analysis of signature genes in DM and HCC. a–e Expression analysis of five signature genes in DM, a-e in order are LY6E, IFITM1, GADD45A, MT1M, and SPP1. f–j Expression analysis of five signature genes in HCC, in order are LY6E, IFITM1, GADD45A, MT1M, and SPP1. k–o Expression analysis of 5 signature genes in HCC validated by TCGA data, in order LY6E, IFITM1, GADD45A, MT1M, and SPP1. **P < 0.005, ***P < 0.001. Con: Normal tissure. Treat: Disease (DC or HCC)

Back to article page